| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1998 Oxford University Press
other |
Enteric Reovirus Infection as a Probe to Study Immunotoxicity of the Gastrointestinal Tract1
Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine Morganlown, West Virginia 26506
Received September 15, 1997; accepted January 9, 1998
The gastrointestinal (GI) tract contains a complex immune system that defends the host against a wide range of pathogens and toxins. The GI tract is also exposed to many environmental toxins that could adversely affect intestinal immunity, and few systems to study immunotoxicity of the GI tract have been described. We demonstrate that intestinal reovirus infection can be used as a system to assess the effects of toxins on intestinal and systemic immunity. Mice were given various doses of cyclophosphamide (CY) for 5 days at doses ranging from 100 to 500 mg/kg by the oral route or 200 mg/kg by the intraperitoneal route. On day 3 of dosing, mice were orally infected with reovirus serotype 1, strain Lang. The effects of CY on viral clearance, intestinal and systemic immune responses, and distribution of intestinal lymphocytes were assessed. Mice treated with CY failed to clear the virus in a dose-dependent manner, and serum anti-reovirus antibody titers were suppressed. Virus-specific IgA in cultures of intestinal tissue from CY-treated mice was significantly reduced compared to controls, although total IgA production was not affected. The virus-specific cytotoxic T-cell response in spleen was also suppressed in CY-treated animals. Cyclophosphamide treatment reduced the number and percentage of B-cells in Peyer's patches. Reovirus infection did not increase cellularity of Peyer's patches in CY-treated mice. Cyclophosphamide treatment also had little effect on the phenotype of intestinal intraepithelial lymphocytes. These data demonstrate that intestinal reovirus infection is useful in studying exposure of the GI tract to immunotoxic agents.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Beli, M. Li, C. Cuff, and J. J. Pestka Docosahexaenoic Acid-Enriched Fish Oil Consumption Modulates Immunoglobulin Responses to and Clearance of Enteric Reovirus Infection in Mice J. Nutr., April 1, 2008; 138(4): 813 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Kuper, M. Van Zijverden, C. Klaassen, M. Tegelenbosch-Schouten, and A. P.M. Wolterbeek Effects of Cyclosporin A and Cyclophosphamide on Peyer's Patches in Rat, Exposed in utero and Neonatally or During Adult Age Toxicol Pathol, February 1, 2007; 35(2): 226 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Li, J. R. Harkema, C. F. Cuff, and J. J. Pestka Deoxynivalenol Exacerbates Viral Bronchopneumonia Induced by Respiratory Reovirus Infection Toxicol. Sci., February 1, 2007; 95(2): 412 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Li, C. F. Cuff, and J. Pestka Modulation of Murine Host Response to Enteric Reovirus Infection by the Trichothecene Deoxynivalenol Toxicol. Sci., September 1, 2005; 87(1): 134 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Fulton, J. Smith, C. Cunningham, and C. F. Cuff Influence of the Route of Infection on Development of T-Cell Receptor {beta}-Chain Repertoires of Reovirus-Specific Cytotoxic T Lymphocytes J. Virol., February 1, 2004; 78(3): 1582 - 1590. [Abstract] [Full Text] [PDF]
|
|